𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An Open-Label Pilot Study of Cannabis-Based Extracts for Bladder Dysfunction in Advanced Multiple Sclerosis

✍ Scribed by WEIN, A

Book ID
125478500
Publisher
Lippincott Williams and Wilkins
Year
2005
Tongue
English
Weight
52 KB
Volume
173
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral fumaric acid esters for the treatme
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study
✍ S. Schimrigk; N. Brune; K. Hellwig; C. Lukas; B. Bellenberg; M. Rieks; V. Hoffma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

An exploratory, prospective, open‐label study of fumaric acid esters (FAE, Fumaderm®) was conducted in patients with relapsing–remitting multiple sclerosis (RRMS). The study consisted of the following four phases: 6‐week baseline, 18‐week treatment (target dose of 720 mg/day), 4‐week washout, and a

Comparison of pelvic floor muscle traini
Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: A randomized pilot study
✍ D. McClurg; R.G. Ashe; K. Marshall; A.S. Lowe-Strong 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

## Abstract ## Aim Bladder dysfunction affects up to 90% of the multiple sclerosis (MS) population. Interventions such as Pelvic Floor Training and Advice (PFTA), Electromyography (EMG) Biofeedback, and Neuromuscular Electrical Stimulation (NMES) have received limited research attention within thi